Literature DB >> 16794136

MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.

Satoshi Goshima1, Masayuki Kanematsu, Hiroshi Kondo, Ryujiro Yokoyama, Toshiharu Miyoshi, Hironori Nishibori, Hiroki Kato, Hiroaki Hoshi, Minoru Onozuka, Noriyuki Moriyama.   

Abstract

OBJECTIVE: The purpose of our study was to determine the optimal scan delays required for hepatic arterial and portal venous phase imaging and for the detection of hypervascular hepatocellular carcinomas (HCCs) in contrast-enhanced MDCT of the liver using a bolus-tracking program. SUBJECTS AND METHODS: CT images (2.5-mm collimation, 5-mm thickness with no intersectional gap) detected an increase in the CT value of 50 H in the lower thoracic aorta. The images were obtained after an IV bolus injection of 2 mL/kg of nonionic iodine contrast material (300 mg I/mL) at 4 mL/s in 171 patients, who were prospectively randomized into three groups with scans commencing at 5, 20, and 45 seconds; 10, 25, and 50 seconds; and 15, 30, and 55 seconds for the first (acquisition time: 4.3 seconds), second (4.3 seconds), and third (9.1 seconds) phases, respectively, after a bolus-tracking program. CT values of the aorta, spleen, proximal portal veins, liver parenchyma, and hepatic veins were measured. Increases in CT values from unenhanced to contrast-enhanced CT were assessed using a contrast enhancement index (CEI). Spleen-to-liver and HCC-to-liver contrasts were also assessed. A qualitative degree of contrast enhancement in each organ was prospectively assessed by two independent radiologists.
RESULTS: At 10-15 seconds, the CEI of the aorta reached 300-336 H and that of the spleen reached 97-108 H without significant enhancement of liver parenchyma (15-25 H). The CEI of the proximal portal veins moderately increased (75-104 H) at 10-15 seconds, but no significant enhancement of hepatic veins was observed (24-51 H). The CEI of liver parenchyma peaked (59-63 H) at 45-55 seconds, when the CEIs of the aorta (117-125 H) and spleen (73-82 H) decreased. Spleen-to-liver contrast (81-84 H) was highest at 10-20 seconds and HCC-to-liver contrast (39-44 H) was highest at 10-15 seconds. The qualitative results correlated well with quantitative results.
CONCLUSION: The optimal scan delays for hepatic arterial and portal venous phases after the bolus-tracking program detected threshold enhancement by 50 H in the lower thoracic aorta for the detection of hypervascular HCCs were 10-15 and 45-55 seconds, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794136     DOI: 10.2214/AJR.04.1878

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  Standardisation of liver MDCT by tracking liver parenchyma enhancement to trigger imaging.

Authors:  H Brodoefel; A Tognolini; G A Zamboni; S Gourtsoyianni; C D Claussen; V Raptopoulos
Journal:  Eur Radiol       Date:  2011-11-05       Impact factor: 5.315

2.  Reduction of the unnecessary dose from the over-range area with a spiral dynamic z-collimator: comparison of beam pitch and detector coverage with 128-detector row CT.

Authors:  Takashi Shirasaka; Yoshinori Funama; Mutsukazu Hayashi; Shinichi Awamoto; Masatoshi Kondo; Yasuhiko Nakamura; Masamitsu Hatakenaka; Hiroshi Honda
Journal:  Radiol Phys Technol       Date:  2011-10-15

3.  Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.

Authors:  Isao Yamaguchi; Eiji Kidoya; Masayuki Suzuki; Hirohiko Kimura
Journal:  Radiol Phys Technol       Date:  2010-09-25

4.  Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.

Authors:  A Guerrisi; D Marin; R C Nelson; G De Filippis; M Di Martino; H Barnhart; R Masciangelo; I Guerrisi; R Passariello; C Catalano
Journal:  Br J Radiol       Date:  2011-08       Impact factor: 3.039

5.  Operation of bolus tracking system for prediction of aortic peak enhancement at multidetector row computed tomography: pharmacokinetic analysis and clinical study.

Authors:  Isao Yamaguchi; Hiroyuki Hayashi; Masayuki Suzuki; Katsuhiro Ichikawa; Eiji Kidoya; Hirohiko Kimura
Journal:  Radiat Med       Date:  2008-07-27

6.  Correlation of abdominal fat ratio with hepatic CT enhancement.

Authors:  Qing Zhang; Mu-Jie Guo; Yu-Fen Wu
Journal:  Exp Ther Med       Date:  2015-05-06       Impact factor: 2.447

Review 7.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

8.  Graphics Processing Unit-Accelerated Nonrigid Registration of MR Images to CT Images During CT-Guided Percutaneous Liver Tumor Ablations.

Authors:  Junichi Tokuda; William Plishker; Meysam Torabi; Olutayo I Olubiyi; George Zaki; Servet Tatli; Stuart G Silverman; Raj Shekher; Nobuhiko Hata
Journal:  Acad Radiol       Date:  2015-03-14       Impact factor: 3.173

9.  Determination of optimal intravenous contrast agent iodine dose for the detection of liver metastasis at 80-kVp CT.

Authors:  Satoshi Goshima; Masayuki Kanematsu; Yoshifumi Noda; Hiroshi Kondo; Haruo Watanabe; Hiroshi Kawada; Nobuyuki Kawai; Yukichi Tanahashi; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

10.  Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight?

Authors:  Hiroshi Kondo; Masayuki Kanematsu; Satoshi Goshima; Haruo Watanabe; Hiroshi Kawada; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2013-03-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.